Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.

Abdulrahman E KoshakEmad A KoshakAbdullah F MobeireekMazen A BadawiSiraj O WaliHusam M MalibaryAli F AtwahMeshari M AlhamdanReem A AlmalkiTariq A Madani

Published in: Trials (2020)

The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol.

Keyphrases

randomized controlled trial
clinical trial
coronavirus disease
study protocol
sars cov